These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 16900017

  • 1. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A, Kowey PR.
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [Abstract] [Full Text] [Related]

  • 2. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK, Zipes DP.
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [Abstract] [Full Text] [Related]

  • 4. Prevention of sudden cardiac death.
    Goldberger JJ.
    Heart Dis; 2000 May; 2(4):305-13. PubMed ID: 11728274
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH, Gold MR.
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [Abstract] [Full Text] [Related]

  • 7. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M.
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic therapy in heart failure.
    Eckardt L, Haverkamp W, Breithardt G.
    Heart Fail Monit; 2002 Feb; 2(4):110-9. PubMed ID: 12634885
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL, Proclemer A, Luzi M, Ruffa F, Gorgoglione MG, Ferrari G.
    Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
    [Abstract] [Full Text] [Related]

  • 13. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F, Loma-Osorio A, Torres Bosco A.
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W, Maisch B.
    Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B.
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [Abstract] [Full Text] [Related]

  • 18. [Arrhythmias in cardiomyopathies].
    Kaneko Y, Kurabayashi M.
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [Abstract] [Full Text] [Related]

  • 19. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF, Capucci A.
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.